Heike Keilhack

Chief Scientific Officer, ROME Therapeutics

Belmont, California

About

Female

Heike Keilhack is the current Chief Scientific Officer of ROME Therapeutics. She previously worked at Ribon Therapeutics as a Chief Scientific Officer. Heike Keilhack attended Martin Luther University of Halle-Wittenberg.

Experience

ROME Therapeutics

Chief Scientific Officer

View →

Growth39Cambridge, Massachusetts, United StatesBio Health · Biotechnology

Education

Martin Luther University of Halle-Wittenberg · Dipl. Biochem., Biochemistry
1991 – 1996

Headlines from Google News. Social posts load from the platform only when you open a tab.

ROME Therapeutics, Enara Bio, Nucleome Therapeutics and NYU
GlobeNewswire · Oct 8
Up and down the ladder: The latest comings and goings
STAT · Jan 12
ROME Therapeutics Appoints Heike Keilhack, Ph.D., as Chief Scientific Officer
citybiz · Jan 4

People at ROME Therapeutics

Benjamin Greenbaum

David Ting

Rosana Kapeller

Data from: crunchbase